OXY Occidental Petroleum

Dividend
1.78%
Previous close
$55.91
Est. 12 months change
+16.58%
Projected Price
$65.27

Profitability Metrics

Return on Equity (ROE)
14.93%
Return on Assets (ROA)
6.74%
Return on Invested Capital (ROIC)
7.16%
Weighted Average Cost of Capital (WACC)
5.13%
ROIC - WACC
2.02%
Updated : 2026-08-07 19:53 ET

Valuation Metrics

P/E Ratio
12.57
Forward P/E
11.59
PEG Ratio
1.00
Debt Current Ratio
1.41

Growth & Cash Flow

Gross Margin
58.66%
Operating Margin
26.47%
FCF Margin
20.52%
TTM Revenue Growth
57.08%
Projected 12M EPS Growth
8.51%

Price Change

Price % from 50 SMA
19.33%
Price % from 200 SMA
37.64%
6 Months
42.37%
1 Year
27.65%
2 Years
-6.38%
Click here to see the list of ETFs containing OXY as a top holding :Occidental Petroleum ETFs

Analysis

Company Overview

Occidental Petroleum is an integrated oil and gas exploration, production, and chemicals company with operations across the United States, the Middle East, and Latin America. Sector: Energy.

Overview

Occidental Petroleum (OXY) is an individual stock. The analysis below presents key financial metrics for the company, covering profitability, capital efficiency, valuation, margins, and growth.

Profitability & Capital Efficiency

From a capital efficiency perspective, ROIC is 7.16%, WACC is 5.13%, and the economic spread is 2.02%. On balance, the company marginally exceed their cost of capital, suggesting modest but present value creation. Supporting metrics show ROE at 14.93% and ROA at 6.74%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a company that is value-creative but with less room for execution slippage.

Valuation

Turning to how the market is pricing the underlying earnings, trailing P/E of 12.57, forward P/E of 11.59, PEG of 1.00. Trailing and forward valuations are closely aligned, pointing to a market that is pricing continuity rather than improvement in the earnings outlook. A sub-1.5 PEG is a positive signal, indicating the company's earnings growth expectations are more than adequate to justify current prices. At 1.41, the aggregate current ratio reflects the company with limited near-term liquidity buffer. The combined picture across P/E, forward P/E, PEG, and current ratio suggests a company that is priced for continued execution — where disappointment would be costly and outperformance would likely require positive earnings surprises.

Margins & Cash Generation

On the margin front: gross margin sits at 58.66%, operating margin at 26.47%, and free cash flow margin at 20.52%. At this level, the company reflects reasonable cost discipline and adequate pricing leverage at the production layer. Operating margins sit in a healthy range — not exceptional, but indicating reasonable operational efficiency. Strong free cash flow margins point to businesses with meaningful financial flexibility and limited dependence on external capital. This margin set supports the view that earnings quality is high and cash generation is not merely accounting-driven.

Growth & Forward Outlook

On the forward picture: TTM revenue growth of 57.08% reflecting robust top-line expansion across the company. Forecasted EPS growth of 8.5% over the next year is supportive of the current valuation, suggesting the market is not paying for earnings that won't arrive. Analyst price targets suggest street expectations imply a constructive but measured return profile on a 12-month view. Revenue growth is grounded in reported results; price targets are forward projections that embed assumptions about multiple expansion, earnings delivery, and macro conditions. The key risk in both directions is whether the company can maintain their operating trajectory as macro and sector conditions evolve. The estimated 12-month price change is based on analyst consensus price target estimates, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

Conclusion

Strong Buy

Across the metrics reviewed, the evidence is consistently constructive — quality, growth, and valuation are pulling in the same direction.

This assessment is based solely on the quantitative metrics presented above and does not constitute financial advice. Investors should consider their own risk tolerance and conduct independent research before making investment decisions.